You can buy or sell Aptinyx and other stocks, options, ETFs, and crypto commission-free!
Aptinyx Inc. Common Stock, also called Aptinyx, is a clinical stage biopharmaceutical company. Read More It engages in the discovery, development, and and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. The company was founded by Norbert G. Riedel and Joseph R. Moskal in June 2015 and is headquartered in Evanston, IL.
52 Week High
52 Week Low
— per share
Expected May 12, After Hours